Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. more
Time Frame | NDRA | Sector | S&P500 |
---|---|---|---|
1-Week Return | 27.56% | -0.94% | -2.6% |
1-Month Return | 1.45% | -5.08% | -1.08% |
3-Month Return | -25.69% | -10.62% | 3.45% |
6-Month Return | -97.11% | -6.18% | 8.57% |
1-Year Return | -99.82% | 1.98% | 24.3% |
3-Year Return | -99.62% | -0.93% | 25.58% |
5-Year Return | -99.73% | 33.84% | 84.07% |
10-Year Return | -99.92% | 102.52% | 185.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 115.01K | 165.25K | 224.41K | 234.26K | 275.45K | [{"date":"2019-12-31","value":41.75,"profit":true},{"date":"2020-12-31","value":59.99,"profit":true},{"date":"2021-12-31","value":81.47,"profit":true},{"date":"2022-12-31","value":85.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (115.01K) | (165.25K) | (224.41K) | (234.26K) | (275.45K) | [{"date":"2019-12-31","value":-11501100,"profit":false},{"date":"2020-12-31","value":-16524900,"profit":false},{"date":"2021-12-31","value":-22441500,"profit":false},{"date":"2022-12-31","value":-23425800,"profit":false},{"date":"2023-12-31","value":-27545100,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 10.84M | 11.50M | 11.50M | 13.16M | 10.52M | [{"date":"2019-12-31","value":82.41,"profit":true},{"date":"2020-12-31","value":87.42,"profit":true},{"date":"2021-12-31","value":87.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.96,"profit":true}] |
Operating Income | (10.84M) | (11.50M) | (11.50M) | (13.16M) | (10.52M) | [{"date":"2019-12-31","value":-1084359200,"profit":false},{"date":"2020-12-31","value":-1150191700,"profit":false},{"date":"2021-12-31","value":-1149830500,"profit":false},{"date":"2022-12-31","value":-1315755900,"profit":false},{"date":"2023-12-31","value":-1052073500,"profit":false}] |
Total Non-Operating Income/Expense | (4.82M) | (456.01K) | 267.06K | - | - | [{"date":"2019-12-31","value":-1804.06,"profit":false},{"date":"2020-12-31","value":-170.76,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (13.31M) | (11.73M) | (11.23M) | (13.18M) | (10.06M) | [{"date":"2019-12-31","value":-1330596400,"profit":false},{"date":"2020-12-31","value":-1172550100,"profit":false},{"date":"2021-12-31","value":-1123125000,"profit":false},{"date":"2022-12-31","value":-1317909200,"profit":false},{"date":"2023-12-31","value":-1006025000,"profit":false}] |
Income Taxes | 2.25M | 241.27K | (41.55K) | 21.53K | (1.00) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":10.73,"profit":true},{"date":"2021-12-31","value":-1.85,"profit":false},{"date":"2022-12-31","value":0.96,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (15.55M) | (11.97M) | (11.19M) | - | - | [{"date":"2019-12-31","value":-1555453000,"profit":false},{"date":"2020-12-31","value":-1196676900,"profit":false},{"date":"2021-12-31","value":-1118970500,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (13.31M) | (11.73M) | (11.23M) | (13.18M) | (11.89M) | [{"date":"2019-12-31","value":-1330596400,"profit":false},{"date":"2020-12-31","value":-1172550100,"profit":false},{"date":"2021-12-31","value":-1123125000,"profit":false},{"date":"2022-12-31","value":-1317909200,"profit":false},{"date":"2023-12-31","value":-1189031000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (15.55M) | (11.97M) | (11.19M) | (13.20M) | (10.06M) | [{"date":"2019-12-31","value":-1555453000,"profit":false},{"date":"2020-12-31","value":-1196676900,"profit":false},{"date":"2021-12-31","value":-1118970500,"profit":false},{"date":"2022-12-31","value":-1320062500,"profit":false},{"date":"2023-12-31","value":-1006025000,"profit":false}] |
EPS (Diluted) | (46.80) | (14.80) | (5.60) | (4.56) | (1.81) | [{"date":"2019-12-31","value":-4680,"profit":false},{"date":"2020-12-31","value":-1480,"profit":false},{"date":"2021-12-31","value":-560,"profit":false},{"date":"2022-12-31","value":-456,"profit":false},{"date":"2023-12-31","value":-181,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NDRA | |
---|---|
Cash Ratio | 5.83 |
Current Ratio | 6.10 |
Quick Ratio | 2.76 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NDRA | |
---|---|
ROA (LTM) | -60.94% |
ROE (LTM) | -120.13% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NDRA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.21 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.79 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NDRA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.45 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
PEG | NM |
ENDRA Life Sciences Inc (NDRA) share price today is $5.6
Yes, Indians can buy shares of ENDRA Life Sciences Inc (NDRA) on Vested. To buy ENDRA Life Sciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NDRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ENDRA Life Sciences Inc (NDRA) via the Vested app. You can start investing in ENDRA Life Sciences Inc (NDRA) with a minimum investment of $1.
You can invest in shares of ENDRA Life Sciences Inc (NDRA) via Vested in three simple steps:
The 52-week high price of ENDRA Life Sciences Inc (NDRA) is $4663.75. The 52-week low price of ENDRA Life Sciences Inc (NDRA) is $4.01.
The price-to-earnings (P/E) ratio of ENDRA Life Sciences Inc (NDRA) is
The price-to-book (P/B) ratio of ENDRA Life Sciences Inc (NDRA) is 0.45
The dividend yield of ENDRA Life Sciences Inc (NDRA) is 0.00%
The market capitalization of ENDRA Life Sciences Inc (NDRA) is $2.96M
The stock symbol (or ticker) of ENDRA Life Sciences Inc is NDRA